Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma
Authors
Keywords
-
Journal
Cancers
Volume 10, Issue 9, Pages 328
Publisher
MDPI AG
Online
2018-09-13
DOI
10.3390/cancers10090328
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An eight-miRNA signature expression-based risk scoring system for prediction of survival in pancreatic adenocarcinoma
- (2018) Daoqin Dou et al. Cancer Biomarkers
- Personalized RNA Medicine for Pancreatic Cancer
- (2018) Maud-Emmanuelle Gilles et al. CLINICAL CANCER RESEARCH
- Clinical Implication of MicroRNAs in Molecular Pathology
- (2018) Seema Sethi et al. CLINICS IN LABORATORY MEDICINE
- The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network
- (2018) Xiaochao Tan et al. JOURNAL OF CLINICAL INVESTIGATION
- Pre-operative Plasma miR-21-5p Is a Sensitive Biomarker and Independent Prognostic Factor in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Surgical Resection
- (2018) PETR KARASEK et al. Cancer Genomics & Proteomics
- Blood-Derived microRNAs for Pancreatic Cancer Diagnosis: A Narrative Review and Meta-Analysis
- (2018) Xiaodong Li et al. Frontiers in Physiology
- Epigenetics of epithelial-to-mesenchymal transition in pancreatic carcinoma
- (2017) Max M. Träger et al. INTERNATIONAL JOURNAL OF CANCER
- Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study
- (2017) Eric J. Duell et al. INTERNATIONAL JOURNAL OF CANCER
- Novel Diagnostic and Predictive Biomarkers in Pancreatic Adenocarcinoma
- (2017) John C. Chang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma
- (2017) Ning Jiang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancreatic Cancer
- (2017) Goutam Mondal et al. MOLECULAR PHARMACEUTICS
- The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
- (2017) Angela M. Krebs et al. NATURE CELL BIOLOGY
- MicroRNA-148a suppresses epithelial-mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/β-catenin signaling pathway
- (2017) Long Peng et al. ONCOLOGY REPORTS
- miR‑203a suppresses cell proliferation by targeting E2F transcription factor 3 in human gastric cancer
- (2017) Huiqin Yang et al. Oncology Letters
- miR-34a inhibits pancreatic cancer progression through Snail1-mediated epithelial–mesenchymal transition and the Notch signaling pathway
- (2017) Yan Tang et al. Scientific Reports
- Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review
- (2017) Shuai Wang et al. Biomed Research International
- Evaluation of Plasma MicroRNAs as Diagnostic and Prognostic Biomarkers in Pancreatic Adenocarcinoma: miR-196a and miR-210 Could Be Negative and Positive Prognostic Markers, Respectively
- (2017) Qi Yu et al. Biomed Research International
- Prognostic Role of the MicroRNA-200 Family in Various Carcinomas: A Systematic Review and Meta-Analysis
- (2017) Jung Soo Lee et al. Biomed Research International
- Molecular mechanisms of microRNAs in regulating epithelial–mesenchymal transitions in human cancers
- (2016) Jinlong Tang et al. CANCER LETTERS
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- Global Trends in Pancreatic Cancer Mortality From 1980 Through 2013 and Predictions for 2017
- (2016) Aimee L. Lucas et al. Clinical Gastroenterology and Hepatology
- Epithelial-to-mesenchymal transition drives a pro-metastatic Golgi compaction process through scaffolding protein PAQR11
- (2016) Xiaochao Tan et al. JOURNAL OF CLINICAL INVESTIGATION
- MicroRNA-148a Suppresses the Proliferation and Migration of Pancreatic Cancer Cells by Down-regulating ErbB3
- (2016) Hui Feng et al. PANCREAS
- miRNA-21 and miRNA-34a Are Potential Minimally Invasive Biomarkers for the Diagnosis of Pancreatic Ductal Adenocarcinoma
- (2016) Bárbara Alemar et al. PANCREAS
- miR-148a and miR-375 may serve as predictive biomarkers for early diagnosis of laryngeal carcinoma
- (2016) Ying Wu et al. Oncology Letters
- New combined microRNA and protein plasmatic biomarker panel for pancreatic cancer
- (2016) Wei Yuan et al. Oncotarget
- Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells
- (2016) James A. McCubrey et al. Oncotarget
- Signal Transduction Pathways of EMT Induced by TGF-β, SHH, and WNT and Their Crosstalks
- (2016) Jingyu Zhang et al. Journal of Clinical Medicine
- miRNAs in pancreatic cancer: Therapeutic potential, delivery challenges and strategies
- (2015) Deepak Chitkara et al. ADVANCED DRUG DELIVERY REVIEWS
- Combination of microRNA therapeutics with small-molecule anticancer drugs: Mechanism of action and co-delivery nanocarriers
- (2015) Xin Dai et al. ADVANCED DRUG DELIVERY REVIEWS
- Epithelial–mesenchymal transition in pancreatic cancer: Is it a clinically significant factor?
- (2015) Jia-Hao Jiang et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The Interplay Between miR-148a and DNMT1 Might be Exploited for Pancreatic Cancer Therapy
- (2015) Qian Zhan et al. CANCER INVESTIGATION
- ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance
- (2015) Peijing Zhang et al. CELL CYCLE
- High Expression of MicroRNA-196a Indicates Poor Prognosis in Resected Pancreatic Neuroendocrine Tumor
- (2015) Yoon Suk Lee et al. MEDICINE
- Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma
- (2015) Sameer A. Dhayat et al. PLoS One
- The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy
- (2015) Brock Humphries et al. Oncotarget
- MicroRNA-100 and microRNA-21 as markers of survival and chemotherapy response in pancreatic ductal adenocarcinoma UICC stage II
- (2015) Sameer Abdallah Dhayat et al. Clinical Epigenetics
- MicroRNA Profiling Implies New Markers of Gemcitabine Chemoresistance in Mutant p53 Pancreatic Ductal Adenocarcinoma
- (2015) Sameer A. Dhayat et al. PLoS One
- How to Explain the Contradiction of microRNA 200c Expression and Survival in Solid Tumors?: a Meta-analysis
- (2014) Hui-Yu Wang et al. Asian Pacific Journal of Cancer Prevention
- A Family of Pleiotropically Acting MicroRNAs in Cancer Progression, miR-200: Potential Cancer Therapeutic Targets
- (2014) Hai-Feng Zhang et al. CURRENT PHARMACEUTICAL DESIGN
- The role of miR-148a in gastric cancer
- (2014) Jiazeng Xia et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- miR-200–containing extracellular vesicles promote breast cancer cell metastasis
- (2014) Minh T.N. Le et al. JOURNAL OF CLINICAL INVESTIGATION
- The microRNA-200 family-A potential diagnostic marker in hepatocellular carcinoma?
- (2014) Sameer A. Dhayat et al. JOURNAL OF SURGICAL ONCOLOGY
- Circulating miR-148a is a significant diagnostic and prognostic biomarker for patients with osteosarcoma
- (2014) Wanli Ma et al. TUMOR BIOLOGY
- Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening
- (2014) Jin-shan Yang et al. TUMOR BIOLOGY
- MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancer
- (2014) Marion Gayral WORLD JOURNAL OF GASTROENTEROLOGY
- Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer
- (2014) Jin Wang et al. Journal of Cancer
- Serum miR-200c Is a Novel Prognostic and Metastasis-Predictive Biomarker in Patients With Colorectal Cancer
- (2013) Yuji Toiyama et al. ANNALS OF SURGERY
- MiR-200, a new star miRNA in human cancer
- (2013) Xiangling Feng et al. CANCER LETTERS
- Prospects of miRNA-Based Therapy for Pancreatic Cancer
- (2013) Priya Pai et al. CURRENT DRUG TARGETS
- microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions
- (2013) H Ouyang et al. ONCOGENE
- miR-655 Is an EMT-Suppressive MicroRNA Targeting ZEB1 and TGFBR2
- (2013) Yosuke Harazono et al. PLoS One
- MiR-148a regulates the growth and apoptosis in pancreatic cancer by targeting CCKBR and Bcl-2
- (2013) Rui Zhang et al. TUMOR BIOLOGY
- Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9
- (2013) Umashankar K. Ballehaninna et al. TUMOR BIOLOGY
- miRNA profiling in pancreatic cancer and restoration of chemosensitivity
- (2012) Saurabh Singh et al. CANCER LETTERS
- Meta-Analysis of the Prognostic Value of Circulating Tumor Cells in Breast Cancer
- (2012) L. Zhang et al. CLINICAL CANCER RESEARCH
- miR-197 induces epithelial-mesenchymal transition in pancreatic cancer cells by targeting p120 catenin
- (2012) Shin Hamada et al. JOURNAL OF CELLULAR PHYSIOLOGY
- ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression
- (2012) Young-Ho Ahn et al. JOURNAL OF CLINICAL INVESTIGATION
- Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer
- (2012) Jordan M. Winter et al. JOURNAL OF SURGICAL ONCOLOGY
- Targeted Expression of miR-34a Using the T-VISA System Suppresses Breast Cancer Cell Growth and Invasion
- (2012) Laisheng Li et al. MOLECULAR THERAPY
- Cancer stem cells and epithelial–mesenchymal transition: Concepts and molecular links
- (2012) Christina Scheel et al. SEMINARS IN CANCER BIOLOGY
- miR-34 – a microRNA replacement therapy is headed to the clinic
- (2012) Andreas G. Bader Frontiers in Genetics
- MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma
- (2011) N. B. Jamieson et al. CLINICAL CANCER RESEARCH
- The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells
- (2011) Simone Brabletz et al. EMBO JOURNAL
- Restitution of Tumor Suppressor MicroRNAs Using a Systemic Nanovector Inhibits Pancreatic Cancer Growth in Mice
- (2011) D. Pramanik et al. MOLECULAR CANCER THERAPEUTICS
- Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in Mice
- (2011) Phong Trang et al. MOLECULAR THERAPY
- Circulating Plasma MiR-141 Is a Novel Biomarker for Metastatic Colon Cancer and Predicts Poor Prognosis
- (2011) Hanyin Cheng et al. PLoS One
- The role of the miR-200 family in epithelial-mesenchymal transition
- (2010) Perry S. Mongroo et al. CANCER BIOLOGY & THERAPY
- Pancreatic Cancers Epigenetically Silence SIP1 and Hypomethylate and Overexpress miR-200a/200b in Association with Elevated Circulating miR-200a and miR-200b Levels
- (2010) A. Li et al. CANCER RESEARCH
- Meta-analysis Shows That Detection of Circulating Tumor Cells Indicates Poor Prognosis in Patients With Colorectal Cancer
- (2010) Nuh N. Rahbari et al. GASTROENTEROLOGY
- MicroRNA, hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation
- (2010) Jun Yu et al. Molecular Cancer
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs
- (2009) Ulrich Wellner et al. NATURE CELL BIOLOGY
- MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
- (2009) Qing Ji et al. PLoS One
- A Double-Negative Feedback Loop between ZEB1-SIP1 and the microRNA-200 Family Regulates Epithelial-Mesenchymal Transition
- (2008) C. P. Bracken et al. CANCER RESEARCH
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation